CRISPR Therapeutics AG | Collaboration Agreements | Business Contracts

First Amendment to the Strategic Collaboration and License Agreement dated March 17, 2021, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated (Filed With SEC on April 27, 2021)

Amendment No. 2 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of October 21, 2019 (Filed With SEC on February 12, 2020)

Amendment No. 1 to Research Collaboration Agreement by and between CRISPR Therapeutics AG and ViaCyte, Inc., dated as of April 30, 2019 (Filed With SEC on February 12, 2020)

Amendment No. 2 to the Strategic Collaboration, Option and License Agreement by and between, on the one hand, Vertex Pharmaceuticals Incorporated and Vertex Pharmaceuticals... (Filed With SEC on July 29, 2019)

Strategic Collaboration and License Agreement dated June 6, 2019, between CRISPR Therapeutics AG and Vertex Pharmaceuticals Incorporated (Filed With SEC on July 29, 2019)

CRISPR Therapeutics AG (27) | Collaboration Agreements (5)